Skip to content
GenoLensGenoLens

KDM3B

Chr 5q31.2

lysine demethylase 3B

Aliases:
KIAA1082, NET22
MANE:
ENST00000314358.10

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Childhood solid tumours

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Monogenic hearing loss

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Monogenic short stature

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • Diets-Jongmans syndrome

    0.77
  • hereditary disease

    0.51
  • Neurodevelopmental delay

    0.41
  • syndromic intellectual disability

    0.40
  • neurodevelopmental disorder

    0.37
  • Rare genetic epilepsy

    0.34
  • Rare genetic intellectual disability

    0.34
  • pilocytic astrocytoma

    0.33
  • autism spectrum disorder

    0.28
  • atrial fibrillation

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Lysine-specific demethylase 3B

Histone demethylase that specifically demethylates 'Lys-9' of histone H3, thereby playing a central role in histone code. Demethylation of Lys residue generates formaldehyde and succinate. May have tumor suppressor activity

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.